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Abstract
 .Cerebellar granule cells CGCs explanted in vitro undergo death via apoptosis when the concentration of potassium is shifted from 25
mM to 5 mM. We report that adenosine and ADP, which act as neurotransmitters and neuromodulators in the brain, exert in cultured
cerebellar granule cells a specific and marked antiapoptotic action with half-maximal effect in the 10–100 mM range. The action of
 .adenosine is partly inhibited by the A1AR antagonist 8-cyclopentyl-1,3-dipropylxanthine DPCPX and is mimicked by the A1AR agonist
 .2-chloro-N6-cyclopentyladenosine CCPA , while ADP effect, that is completely blocked by the P2x, P2y receptors noncompetitive
antagonist suramine, is restored in the presence of the selective P2x purinoceptors agonist b,g-methylene-L-ATP. These findings
demonstrate that adenosine and ADP markedly inhibit the program of cell death in cerebellar granule cells and suggest that such an action
is mediated via interaction with, respectively, A1 and P2x receptors. q 1998 Elsevier Science B.V. All rights reserved.
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We have previously reported that lowering extracellular
Kq from 25 mM to 5 mM triggers apoptosis in cultured rat
w xcerebellar granule cells 6 via a partial closure of L-type
Ca2q channels with consequent drop of intracellular con-
w xcentrations of this cation 8 . Pharmacological treatments
that counteract the Ca2q drop block apoptosis, while an-i
tagonists of L-type Ca2q channels, such as nifedipine,
q w xcause apoptosis even in 25 mM K 8 . It has been
 . 2qreported that cyclic ADP ribose cADPR releases Ca in
various cell types and its production is achieved by CD38,
a type II transmembrane glycoprotein with properties of
bifunctional ectoenzyme which is present also in cerebellar
 . w xgranule cells CGCs 5 .
In view of the crucial role played by Ca2q homeostasisi
in these neurons and of the action of cADPR in inducing
release of this cation from intracellular stores, we tested
the possibility that this cyclic nucleotide and its precursor
bNAD could counteract the apoptotic pathway. Since only
bNAD, but not cADPR, showed a significant and repro-
 .ducible neuroprotective action see also Fig. 1 , a system-
atic search for the active component of this compound
responsible of the antiapoptotic action was undertaken and
led to identify adenosine and ADP as the constituents fully
endowed with the antiapoptotic activity.
) Corresponding author. Fax: q39-6-86090370
Since nucleotides and nucleosides have been shown or
postulated to play also the function of trophic substances
w x16 , besides a neurotransmitter and neuromodulatory role,
the marked and specific antiapoptotic action exerted on
CGCs first reported in this paper could have relevance to
all conditions whereby a control of the program of cell
death could play a crucial role. Among these are the events
 .controlling the extent and site s of cell death during
development, when approximately 50% of neurons are
doomed to die during formation of neural networks and
several neurodegenerative disorders affecting the adult
brain.
Cultures enriched in granule neurons were obtained
from dissociated cerebella of eight-day-old Wistar rats
 .Charles River Breeding Laboratories , according to the
w xprocedure previously described 13 . Cells were plated in
 .basal medium Eagle BME; GIBCO supplemented with
 .  .fetal bovine serum FBS on four-well dishes NUNC
 .previously coated with poly-L-lysine 10 mgrml . Cellular
density was 0.5=106 cells per well. After 18–22 h,
 .1-b-arabinofuranosylcytosine 10 mM was added to the
culture medium to prevent replication of non-neuronal
cells.
In order to induce apoptosis, after 6–7 DIV, the culture
medium containing 25 mM KCl was replaced with an
identical medium devoid of serum and containing 5 mM
w x  .KCl 6 plus or minus controls the substance tested for its
possible antiapoptotic action. The antagonists were added
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 .Fig. 1. a Survival of neurons in 5 mM KCl after treatment with various
agents. Induction of apoptosis was performed switching 6 DIV-cultured
cerebellar granule cells from culture medium containing 10% FBS and 25
 .mM KCl to serum-free medium with 5 mM KCl and no additives K5 or
 .  .with 10 mM cyclic ADPR cADPR , 100 mM bNAD NAD , 100 mM
 .  .nicotinamide NIC , 100 mM ADP, 100 mM adenine ADN , or 100 mM
 .adenosine ADO . Forty-eight hours later, viable cells were counted and
 .compared to controls in serum-free medium containing 25 mM KCl. b
Concentration dependence of the antiapoptotic action of bNAD and
 .adenosine ADO . Cells treated as above were tested with different
concentrations of bNAD and adenosine. Forty-eight hours later, viable
cells were counted and compared to controls. The maximum antiapoptotic
activity is achieved at 1 mM, whereas half-maximal effect occurs in the
10–100 mM range. Each bar represents mean"S.D. Statistically signifi-
cant differences were estimated with Duncan’s multiple range test. ) Ds
n.s. compared to K5; )) Dss. compared to K5; ))) Dsn.s. com-
pared to 100 mM bNAD. The experiments were repeated four times in
 .duplicate with different cell preparations ns4 .
15 min before addition of corresponding agonists. Controls
underwent the same procedure, but their medium contained
25 mM KCl.
After 24 or 48 h of incubation in 5 mM KCl and 25
mM KCl medium, viable cells were determined by count-
ing intact nuclei at contrast phase microscope as previ-
w x ously described 23 or were processed for TUNEL termi-
.nal UTP end labeling in order to detect DNA degradation
typical of apoptosis. To this aim, the cells were fixed for
10 min in 4% paraformaldehyde, rinsed in Tris–EDTA 0.5
 . mgrml TE , briefly processed in TdT buffer 25 mM
Tris–HCl, 200 mM sodium cacodylate, 5 mM cobalt chlo-
. ride and subsequently incubated with the labeling mix 20
U TdT-Boehringer, 0.5 nmol digoxigenin-11-ddUTP-
.Boehringer in 100 ml TdT buffer for 120 min at 378C.
After the TdT reaction, the cells were rinsed in Tris-
 .buffered saline TBS , incubated in TBS containing 0.3%
Triton X-100 and 2% bovine serum albumin for 60 min
with anti-digoxigenin Fab fragments conjugated with alka-
 .line phosphatase Boehringer diluted 1r250 in TBS-Tri-
ton. After washing in TBS, the colour reaction was visu-
alised by incubating the cells in colour buffer 100 mM
Tris–HCl, 100 mM sodium chloride, 50 mM magnesium
.chloride, pH 9.5 containing 4-nitroblue tetrazolium salt
 .and 5-bromo-4-chloro-3-indolyl phosphate Boehringer .
The reaction was monitored under the microscope and
stopped in TE. The labeled cells withstand intensive cells
washings providing evidence that ddUTP is covalently
incorporated by the TdT and that DNA breaks appearing in
apoptotic cells really function as primer for the in situ
reaction.
Data analysis was performed with Stat-100 software
 .Biosoft . Each test was repeated four or five times in
 .duplicate see the figure legends and collected results
were processed with One-way analysis of variance
 .ANOVA for repeated measurements. If the effect was
 .significant ps0.05 Duncan’s multiple range test post-
hoc analysis was used for multiple comparison of means
 p-0.05 was considered to indicate a significant differ-
.ence . Further, Dss. will be used for a significant Dun-
can’s test result, while Dsn.s. for a not significant one,
compared to controls when not specified.
Adenosine, ADP, bNAD, and DPCPX were from
Sigma. Suramine, CCPA, DPMA, CSC, N 6-benzyl-NECA,
Reactive-blue 2 and b,g-methylene-L-ATP were from RBI.
In a preliminary series of experiments, 6–7 DIV-cul-
tured cerebellar granule cells were switched in 5 mM KCl
 .K5 serum-free medium in the absence or in the presence
of cADPR and of its precursor bNAD. After 24 h, the
extent of cell death via apoptosis was monitored. As can
be seen in Fig. 1a, while cADPR at all concentrations
 .tested 1 mM, 10 mM, 100 mM is not able to block the
 .death process Dsn.s. ; on the contrary, 100 mM bNAD
 .enhances survival from 40.8%"8 mean value"S.D. of
 .the controls in 5 mM KCl to 88.9%"3 Dss. . In order
to assess which constituent of bNAD was endowed with
the anti-apoptotic action, we separately tested nicotin-
 .amide, adenine, adenosine, and ADP Fig. 1a . We found
that neither nicotinamide nor adenine has a significant
 .effect Dsn.s. , whereas adenosine and ADP exhibit an
effect overimpossible to that of bNAD. Concentration-de-
pendent experiments reported in Fig. 1b indicate that the
maximum protective activity is achieved at 1 mM both for
bNAD and adenosine and that half-maximal effect occurs
in the 10–100 mM range. The slightly lower activity of
bNAD at all concentrations tested is probably attributable
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to the fact that in order to be active, it must be first
degraded to adenosine by nucleotidase present in the cyto-
plasmic membrane. The experimental test based on the
evaluation of the extent of cell death does not allow to
calculate in a more precise fashion the concentration pro-
viding half-maximal protection.
Parallel experiments performed with the TUNEL proce-
 .dure Fig. 2 confirm and extend previous findings that the
25 mM to 5 mM KCl shift causes death via apoptosis
characterized by DNA laddering due to fragmentation into
w xinternucleosomal particles 6 . We found that only a frac-
tion of all neurons that, at any given time, have undergone
apoptotic death are labeled with this technique, suggesting
that only for a limited time window neurons undergoing
apoptosis are available for nick end labeling. As shown in
Fig. 2c,d, in the presence of bNAD and adenosine, labeled
neurons are barely detectable, and are comparable to con-
trols kept in 25 mM KCl.
Moreover, morphological examinations at phase con-
 .trast microscope not shown indicate that cultures main-
 .Fig. 2. Prevention of low KCl-induced apoptosis by bNAD and adenosine revealed by TUNEL staining. Six DIV neurons were shifted in low KCl 5 mM
 .  .  .serum-free medium, in the absence b or in the presence of 100 mM bNAD c or 100 mM adenosine d . Forty-eight hours later, cultures were processed
 .with TUNEL technique to detect dead cells and photographed using an inverted light microscope. a Control in 25 mM serum-free medium. Experiments
 .were repeated three times with similar results, thus, pictures are representative fields. Scale bar shown in d : 10 mm.
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tained for 48 h in 5 mM KCl medium supplemented with
bNAD, adenosine, and ADP are populated by a number of
healthy neurons comparable to that detectable in 25 mM
KCl, with well-defined cell bodies and a developed net-
work of neurites, while detached cells, shrunken bodies,
and fragmented neurites are rare in all fields.
Attempts were therefore performed to assess the type of
adenosine receptor responsible of this antiapoptotic activ-
ity, considering that previous studies had shown that A1
adenosine receptors are predominantly expressed in cere-
w xbellum and particularly in CGCs 20,25 and involved in
w xthe neuroprotective activity of purines 14 and that ADP
2q w xinduces Ca influx via P2x receptors 12,22 . To this aim,
the A1AR antagonist 8-cyclopentyl-1,3-dipropylxanthine
 . w xDPCPX 3,17 , the A1AR agonist 2-chloro-N6-cyclo-
 . w xpentyladenosine CCPA 11,17 and the noncompetitive
w xP2x, P2y receptors antagonist suramine 4 were used. As
it can be seen in Fig. 3, in the presence of 10 mM CCPA,
neurons survive 80.0%"6.0; Dss. compared to 5 mM
.KCl to an extent overimpossible to that occurring with
ADP and slightly lower than with adenosine 86.0%"6.0;
.Dsn.s. compared to 100 mM adenosine . On the other
hand, 200 mM DPCPX only in part reverses adenosine
neuroprotection 68.0%"6.0; Dss. compared with 100
.mM adenosine , while suramine completely inhibits the
protection of ADP 35.0%"3.0; Dsn.s. compared to 5
.mM KCl . Controls in 25 mM KCl and in 5 mM KCl
media with DPCPX or suramine alone show that these
substances have no toxic effect at the concentrations em-
 .ployed in these studies not shown . In order to assess the
possible role of the other types of adenosine receptors and
Fig. 3. Survival of neurons after 24 h of treatment in low Kq without
 .  .additives K5 or with adenosine ADO, 100 mM alone or with the
 . A1AR antagonist DPCPX 200 mM , with the A1AR agonist CCPA 10
.mM ,with 100 mM ADP alone or with the noncompetitive P2x, P2y
 .antagonist suramine SUR, 100 mM , with the selective P2x receptor
 .agonist b,g-methylene-L-ATP methATP, 100 mM . ) Dss. compared
to K5; )) Dss. compared to 100 mM ADO; ))) Dsn.s. compared
to 100 mM ADO; )))) Dss. compared to 100 mM ADP. Values are
 .means of five experiments repeated in duplicate ns5 .
which of the two P2 receptors subtypes recognized by
suramine is responsible of ADP protection, we used the
6  .A2AR agonist N -2- 3,5-dimethoxyphenyl -2-2-methyl-
 .phenyl-ethyl adenosine DPMA , the A2 AR antagonista
 .  .1,3,7-trimethyl-8- 3-chlorostyryl xanthine CSC alterna-
tively in association with DPMA and adenosine, the selec-
tive A3AR agonist N 6-benzyl-5’-N-ethylcarboxamidoca-
 6 .denosine N -benzyl-NECA , the P2y receptor antagonist
Reactive-blue 2 and the P2x receptor agonist b,g-methyl-
w x ene-L-ATP 12,17 . Ten micromolars of DPMA 37.4%"
. 66.2; Dsn.s. , 10 mM and 100 mM N -benzyl-NECA
 .47.6%"6.4; Dsn.s. did not influence the viability of
the neurons, while 100 mM DPMA had a toxic action. On
the other hand, 100 mM adenosine was not antagonized by
the addition of 200 mM CSC 72.0%"3.3; Dsn.s.
.compared to 100 mM adenosine , therefore, ruling out the
participation of A2 and A3 receptors in the neuroprotective
activity. As far as suramine inhibition of ADP action is
concerned, we observed that Reactive-blue 2 exerts a toxic
effect on granule cultures at all tested concentrations 20,
.100, 200 mM whereas b,g-methylene-L-ATP elicits a
protective activity already at 10 mM 63.0%"4.2; Ds
.n.s. compared to 10 mM ADP reaching ADP protection
level at 100 mM 75.0%"0.0; Dsn.s. compared to 100
.  .mM ADP Fig. 3 .
The findings reported in this paper demonstrate that
adenosine and ADP inhibit the proapoptotic stimulus of
low extracellular KCl in a concentration-dependent fashion
with half-maximal effect at 10–100 mM and a plateau at
w x1.0 mM. It has been reported 15 that adenosine acts as an
endogenous activator of the cellular antioxidant system
 .and that reactive oxygen species ROS are produced
during apoptosis. Our data suggest that the antiapoptotic
action of adenosine and ADP could be achieved via inhibi-
tion of ROS production during early stages of apoptosis
and that this effect is mediated by the interaction of these
ligands with their receptors. Another action of adenosine
and ADP could consist in restoring ATP levels which are
generally impaired during apoptosis in several cell systems
w x19 . The question then arises as to the possible biological
significance of this effect and of the mechanism through
which it is reached. The observations that CCPA can
mimic adenosine properties, DPCPX partially antagonizes
its antiapoptotic action, and that b,g-methylene-L-ATP
inhibits the death of neurons to the same extent as ADP,
suggest the involvement of both A1AR and P2x purinocep-
tors. Future studies should clarify this problem and eluci-
date whether the antiapoptotic action is achieved by
restoration of Ca2q homeostasis imbalanced by the Ca2qi
drop caused by potassium withdrawal from culture medium
w x  .8 or, alternatively, via activation of alternate pathway s
downstream the Ca2q drop.i
As for the possible functional significance, it is worth
mentioning that adenosine is released in vitro by CGCs
w x21 , that low concentrations of this nucleoside are present
in vivo in the extracellular space and that several physio-
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logical or pathological stimuli may cause its rise via a
w xbidirectional facilitated diffusion 9 or via extracellular
w xdegradation of ATP 24 . Furthermore, electrical and
w xchemical depolarization 2,7 or ischemia-hypoxic condi-
w xtions 3,10 evoke adenosine release in the extracellular
space where it can exert its action both at pre- and
post-synaptic sites by inhibiting the release of excitatory
w x neurotransmitters 1,18 and by decreasing EPSP excita-
. w xtory post-synaptic potential via A1ARs 26 .
Thus, adenosine and its derivatives may exert their
action not only as neurotransmitters and neuromodulators,
but also by stabilizing neuronal functions via different
routes consisting in provoking vasodilation to supply oxy-
w xgen and nutrients 21 , inhibiting excitotoxicity by neuro-
transmitters and preventing neurons from delayed death
via apoptosis as reported in this paper.
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